Company name Facebook Inc
Stock ticker FB
Live stock price [stckqut]FB[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $137.5
Target stock price (averages with growth) $151.73
Target stock price (averages with no growth) $68.59
Target stock price (manual assumptions) $136.51

The following company description is from Google Finance: http://www.google.com/finance?q=fb

Facebook, Inc. is a social networking company. The Company is engaged in developing products that enables users to connect and share through mobile devices and personal computers. It offers various services focused on people, marketers and developers. It offers various platforms for people to share their opinions, ideas, photos and videos, and to engage in other activities. Its products include Facebook, Instagram, Messenger and WhatsApp. The Facebook mobile app and Website enables people to connect, share, discover and communicate with each other on mobile devices and personal computers. Its Messenger is a mobile-to-mobile messaging application available on iOS and Android phones. Instagram is a mobile application and Website that enables people to take photos or videos, and share them with friends and followers. WhatsApp Messenger is a cross-platform mobile messaging application and allows people to exchange messages on iOS, Android, BlackBerry, Windows Phone and Nokia devices.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Facebook Inc.

How was this analysis of Facebook Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $89.21
  • Growth: 0.2
  • Current EPS (TTM): $0.95
  • P/E: 93
  • Future EPS Calc: $2.36
  • Future Stock Price Calc: $219.84
  • Target stock price: $136.5

[/s2If]
I hope that this makes you a Confident Investor.

Company name China Biologic Products Inc
Stock ticker CBPO
Live stock price [stckqut]CBPO[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $1400.03
Target stock price (averages with growth) $480.53
Target stock price (averages with no growth) $67.67
Target stock price (manual assumptions) $125.74

The following company description is from Google Finance: http://www.google.com/finance?q=cbpo

China Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. China Biologic has a product portfolio with over 20 different dosage forms of plasma products. The Company’s principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through two subsidiaries, namely, Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also holds an interest in Xi’an Huitian Blood Products Co., Ltd., a plasma products company. Its products include human albumin, human immunoglobulin, IVIG, thymopolypeptides injection, human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in China Biologic Products Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of China Biologic Products Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $82.62
  • Growth: 0.2
  • Current EPS (TTM): $3.13
  • P/E: 26
  • Future EPS Calc: $7.78
  • Future Stock Price Calc: $202.49
  • Target stock price: $125.73

[/s2If]
I hope that this makes you a Confident Investor.

Apple Inc. [stckqut]AAPL[/stckqut] said it has sold more than 13 million iPhone 6s and iPhone 6s Plus models since their launch, up 30% from last year’s total and a record for the company.

Apple didn’t break down the sales by model or by region. Analysts, many of whom had projected sales between 12 million and 13 million, had noted that the phone’s availability in China from the launch would likely boost sales over the first weekend.

The updated phone includes enhanced battery life, a 12-megapixel camera and a 3-D Touch screen as well as a new rose-gold model. Also helping early sales, analysts said, was a longer lead-time for orders.

Mizuho Securities USA analyst Abhey Lamba said the jump from last year’s initial total of 10 million was “clearly impressive” but reflected the greater initial distribution. “Apple made its new phone available in 12 regions this time, including fast-growing China, versus 10 a year ago,” the analyst said.

Apple said Monday that the latest versions of the iPhone would be available in more than 40 additional countries beginning Oct. 9 and more than 130 countries by year’s end.

Source: Apple Sells 13 Million New iPhones at Launch – WSJ